These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
412 related items for PubMed ID: 16236522
1. Treatment concepts of acute promyelocytic leukemia. Lengfelder E, Saussele S, Weisser A, Büchner T, Hehlmann R. Crit Rev Oncol Hematol; 2005 Nov; 56(2):261-74. PubMed ID: 16236522 [Abstract] [Full Text] [Related]
2. Acute promyelocytic leukemia: recent advances in diagnosis and management. Lo-Coco F, Ammatuna E, Montesinos P, Sanz MA. Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690 [Abstract] [Full Text] [Related]
3. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience]. Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N. Srp Arh Celok Lek; 1995 Aug; 123(11-12):279-85. PubMed ID: 16296239 [Abstract] [Full Text] [Related]
4. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution. Hu J, Shen ZX, Sun GL, Chen SJ, Wang ZY, Chen Z. Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151 [Abstract] [Full Text] [Related]
5. Acute promyelocytic leukemia: a paradigm for differentiation therapy. Grimwade D, Mistry AR, Solomon E, Guidez F. Cancer Treat Res; 2010 Dec; 145():219-35. PubMed ID: 20306254 [Abstract] [Full Text] [Related]
6. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia. Marasca R, Zucchini P, Galimberti S, Leonardi G, Vaccari P, Donelli A, Luppi M, Petrini M, Torelli G. Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155 [Abstract] [Full Text] [Related]
8. A survival study and prognostic factors analysis on acute promyelocytic leukemia at a single center. Xin L, Wan-jun S, Zeng-jun L, Yao-zhong Z, Yun-tao L, Yan L, Chang-chun W, Qiao-chuan L, Ren-chi Y, Ming-zhe H, Jian-xiang W, Lu-gui Q. Leuk Res; 2007 Jun; 31(6):765-71. PubMed ID: 17007927 [Abstract] [Full Text] [Related]
9. Treatment of acute promyelocytic leukaemia. Fenaux P, Chomienne C, Degos L. Best Pract Res Clin Haematol; 2001 Mar; 14(1):153-74. PubMed ID: 11355929 [Abstract] [Full Text] [Related]
10. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia]. Xu XJ, Shi SW, Tang YM, Song H, Yang SL, Wei J, Xu WQ, Pan BH, Chen YH, Zhao FY, Shen HQ, Qian BQ, Zhang LY, Ning BT. Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):28-33. PubMed ID: 17306073 [Abstract] [Full Text] [Related]
11. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen. Thirugnanam R, George B, Chendamarai E, Lakshmi KM, Balasubramanian P, Viswabandya A, Srivastava A, Chandy M, Mathews V. Biol Blood Marrow Transplant; 2009 Nov; 15(11):1479-84. PubMed ID: 19822309 [Abstract] [Full Text] [Related]
12. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients. Dai CW, Zhang GS, Shen JK, Zheng WL, Pei MF, Xu YX, Cao YX, Yi Y, Yang JJ, Peng HL, Zhong HY, Li RJ. Acta Haematol; 2009 Nov; 121(1):1-8. PubMed ID: 19246888 [Abstract] [Full Text] [Related]
13. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients. Gameiro P, Vieira S, Carrara P, Silva AL, Diamond J, Botelho de Sousa A, Mehta AB, Prentice HG, Guimarães JE, Hoffbrand AV, Foroni L, Parreira A. Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366 [Abstract] [Full Text] [Related]
14. How to manage acute promyelocytic leukemia. Mi JQ, Li JM, Shen ZX, Chen SJ, Chen Z. Leukemia; 2012 Aug; 26(8):1743-51. PubMed ID: 22422168 [Abstract] [Full Text] [Related]
15. What is the role of arsenic in newly diagnosed APL? Tallman MS. Best Pract Res Clin Haematol; 2008 Dec; 21(4):659-66. PubMed ID: 19041605 [Abstract] [Full Text] [Related]
16. Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy. Breccia M, Diverio D, Noguera NI, Visani G, Santoro A, Locatelli F, Damiani D, Marmont F, Vignetti M, Petti MC, Lo Coco F. Haematologica; 2004 Jan; 89(1):29-33. PubMed ID: 14754603 [Abstract] [Full Text] [Related]
17. Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study. Kwong YL, Au WY, Chim CS, Pang A, Suen C, Liang R. Am J Hematol; 2001 Apr; 66(4):274-9. PubMed ID: 11279639 [Abstract] [Full Text] [Related]
18. Diagnosis and follow-up of acute promyelocytic leukemia by detection of PML-RAR alpha gene rearrangement. Gau JP, Young JH, Lin TH, Yang YS. Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):175-81. PubMed ID: 10746412 [Abstract] [Full Text] [Related]
19. Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group. de Botton S, Fawaz A, Chevret S, Dombret H, Thomas X, Sanz M, Guerci A, San Miguel J, de la Serna J, Stoppa AM, Reman O, Stamatoulas A, Fey M, Cahn JY, Sotto JJ, Bourhis JH, Parry A, Chomienne C, Degos L, Fenaux P. J Clin Oncol; 2005 Jan 01; 23(1):120-6. PubMed ID: 15534358 [Abstract] [Full Text] [Related]
20. Acute promyelocytic leukemia. New methods in diagnosis and treatment. Varghese L, Janckila A, Yam LT. J Ky Med Assoc; 1999 Feb 01; 97(2):61-5. PubMed ID: 10073058 [Abstract] [Full Text] [Related] Page: [Next] [New Search]